IP Library Granted Patent US 8,926,960
Granted Patent B2
US 8,926,960 · App. 12/814,661 · Granted Jan 6, 2015

Growth inhibition and elimination of methicillin-resistant

Inventors: Wanda Smoragiewicz (Montreal, CA); Barbara Karska-Wysocki (Montreal, CA); Mari Bazo (Montreal, CA); Marcia Ruiz (Dollard-des-Ormeaux, CA); François-Marie Luquet (Paris, FR)
Assignee: Bio-K Plus International Inc.
C12N1/20C12R1/245C12R1/23A01N63/00A23C9/123A23C11/106A23L1/3014A23Y2220/17A61K35/747
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,926,960
App. No.
12/814,661
Granted
Jan 6, 2015
Kind
B2
Abstract

The present invention relates to methicillin-resistant Staphylococcus aureus growth inhibition by lactic acid bacterium strains. More specifically it is directed to the use of lactic acid bacterium strains, compositions comprising lactic acid bacterium strains, methods of use and kits thereof to inhibit the growth of methicillin-resistant Staphylococcus aureus . This invention more specifically relates to the inhibitory effect of lactic acid bacterium strains Lactobacillus acidophilus and Lactobacillus caseion methicillin-resistant Staphylococcus aureus.

Claims (7)

1. A method for inhibiting growth of methicillin-resistant Staphylococcus aureus bacteria comprising contacting methicillin-resistant Staphylococcus aureus bacteria with a composition comprising Lactobacillus acidophilus strain I-1492.

2. The method of claim 1 , wherein the composition further comprises a strain of Lactobacillus casei.

3. The method according to claim 2 , wherein the composition comprises about 25% to about 75% of Lactobacillus acidophilus strain I-1492.

4. The method according to claim 2 , wherein the composition comprises about 33% to about 75% of Lactobacillus acidophilus strain I-1492.

5. The method according to claim 2 , wherein the composition comprises about 50% to about 75% of Lactobacillus acidophilus strain I-1492.

6. The method according to claim 2 , wherein the composition comprises about 65% to about 75% of Lactobacillus acidophilus strain I-1492.

7. The method according to claim 2 , wherein the composition comprises about 75% to about 99% of Lactobacillus acidophilus strain I-1492.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2022
From: KERRY LUXEMBOURG S.A.R.L.
To: KERRY GROUP SERVICES INTERNATIONAL LIMITED
Reel/Frame 058792/0891 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2020
From: BIO-K PLUS INTERNATIONAL INC.
To: KERRY LUXEMBOURG S.A.R.L.
Reel/Frame 054738/0524 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2012
From: UNIVERSITE DU QUEBEC A MONTREAL
To: BIO-K PLUS INTERNATIONAL INC.
Reel/Frame 027593/0036 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2012
From: KARSKA-WYSOCKI, BARBARA
To: UNIVERSITE DU QUEBEC A MONTREAL
Reel/Frame 027584/0462 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2012
From: RUIZ, MARCIA T.; LUQUET, FRANCOIS-MARIE
To: BIO-K PLUS INTERNATIONAL INC.
Reel/Frame 027584/0505 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2012
From: SMORAGIEWICZ, WANDA; BAZO, MARI
To: UNIVERSITE DU QUEBEC A MONTREAL
Reel/Frame 027584/0537 →
Continuity (3)
Continuation 12520215
Provisional Application 60876460 · Dec 22, 2006
Related Publication 20110195057A1 · Aug 11, 2011